|
|
COVID-19 Testing: Group health plans must cover (without cost-sharing, prior authorization, or medical management requirements) COVID-19 testing and items and services furnished to an individual during health care provider office visits (including in-person and telemedicine visits), urgent care center visits, and emergency room visits that result in an order or administration of COVID-19 testing or an evaluation of such individual for purposes of determining the need for such testing. For out-of-network providers, group health plans must reimburse either the cash price, as listed by the provider on a public website, or a lower negotiated rate.
Additionally, pursuant to Internal Revenue Service (“IRS”) Notice 2020-15, high deductible health plans (“HDHPs”) may waive minimum deductibles for COVID-19 testing without jeopardizing their HDHP status.
For more information see our SW Benefits Update, “2021 End of Year Plan Sponsor “To Do” List (Part 1) Health and Welfare.”
|
This requirement will expire at the end of the COVID-19 Public Health Emergency.
Leading up to the end of the COVID-19 Public Health Emergency, group health plans may want to consider:
- Whether to continue to cover COVID-19 testing;
- Whether to impose reasonable medical management techniques on COVID-19 testing;
- Whether HDHP relief under IRS Notice 2020-15 might end at the end of the COVID-19 Public Health Emergency; and
- How to notify plan participants of applicable plan changes (e.g., plan amendment, SMM, etc.).
|
COVID-19 Over-The-Counter (“OTC”) Testing: Group health plans must cover up to 8 FDA approved OTC COVID-19 tests per month without cost-sharing (i.e., deductibles, copayments, or coinsurance), prior authorization, or other medical management requirements. If a plan complies with certain requirements, it can limit its reimbursement for OTC COVID-19 tests from non-preferred pharmacies and other retailers to the actual price or $12 per test (whichever is less).
Additionally, pursuant to IRS Notice 2020-15, HDHPs may waive minimum deductibles for COVID-19 testing without jeopardizing their HDHP status.
For more information see our SW Benefits Update, “Group Health Plans Must Provide Free Over-the-Counter COVID-19 Tests Effective January 15, 2022 – Six *Updated* Takeaways.”
|
This requirement will expire at the end of the COVID-19 Public Health Emergency.
Leading up to the end of the COVID-19 Public Health Emergency, group health plans may want to consider:
- Whether to continue to cover OTC COVID-19 testing;
- Whether to impose reasonable medical management techniques on OTC COVID-19 testing;
- Whether HDHP relief under IRS Notice 2020-15 might end at the end of the COVID-19 Public Health Emergency; and
- How to notify plan participants of applicable plan changes (e.g., plan amendment, SMM, etc.).
|
Mental Health Parity: The agencies provided limited enforcement relief under the MHPAEA by allowing plans to disregard free COVID-19 diagnostic testing and other services required to be covered under Section 6001 of the Families First Coronavirus Response Act (“FFCRA”) for purposes of determining whether a financial requirement or quantitative treatment limitation (1) applies to “substantially all” medical/surgical benefits in a classification, or (2) is more restrictive than the “predominant” level applicable to medical/surgical benefits. For more information see our SW Benefits Update, “2021 End of Year Plan Sponsor “To Do” List (Part 1) Health and Welfare.”
|
This relief will expire at the end of the COVID-19 Public Health Emergency.
Leading up to the end of the COVID-19 Public Health Emergency, group health plans may want to consider whether continuing to provide COVID-19 benefits violates MHPAEA requirements.
|
COVID-19 Vaccinations: Group health plans must cover, without cost-sharing, any item, service, or vaccine intended to prevent or mitigate coronavirus if such item is appropriately recommended by the U.S. Preventive Services Task Force or the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention within 15 business days after such a recommendation is made. For more information see our SW Benefits Update, “2021 End of Year Plan Sponsor “To Do” List (Part 1) Health and Welfare.”
|
The requirement to cover vaccines provided by in-network providers continues beyond the COVID-19 Public Health Emergency and COVID-19 National Emergency. However, the requirement to cover vaccines provided by out-of-network providers expires at the end of the COVID-19 Public Health Emergency.
Leading up to the end of the COVID-19 Public Health Emergency, group health plans may want to consider:
- Whether to continue to cover out-of-network COVID-19 vaccines free of charge;
- Whether to impose reasonable medical management techniques on out-of-network COVID-19 vaccines; and
- How to notify plan participants of applicable plan changes (e.g., plan amendment, SMM, etc.).
|
|
Accordingly, periodically group health plans may want to consider:
- Whether to cover COVID-19 treatment free of charge;
- Whether HDHP relief under IRS Notice 2020-15 might end at the end of the COVID-19 Public Health Emergency; and
- How to notify plan participants of applicable plan changes (e.g., plan amendment, SMM, etc.).
|
|
This relief will expire at the end of the later of the COVID-19 Public Health Emergency and COVID-19 National Emergency for EAPs. However, guidance suggests that on-site medical clinics always are excepted benefits and therefore benefits for COVID-19 diagnosis, testing, and vaccinations do not jeopardize this status.
Leading up to the end of the COVID-19 Public Health Emergency and COVID-19 National Emergency, group health plans may want to consider whether to continue to offer benefits for COVID-19 diagnosis, testing, and vaccinations under an EAP and/or on-site medical clinic and how to notify participants of applicable changes.
|
Telemedicine: HDHPs may, but are not required to, cover telemedicine and other remote care services free of charge before the required deductible is met with respect to services provided on or after January 1, 2020 for plan years beginning on or before December 31, 2021 and for months beginning after March 31, 2022 and before January 1, 2023. For more information see our SW Benefits Blog, “HDHP Telehealth Relief Extended for Remainder of 2022, but Mind the 3-Month Gap in Relief.”
|
Accordingly, effective January 1, 2023, HDHPs should no longer do this to avoid tainting their HDHP status and rendering participants HSA ineligible. HDHPs should also notify plan participants of this change.
|
COVID-19 Deadline Extensions: ERISA health and welfare plans must extend various deadlines during the “outbreak period” related to the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), special enrollment, and claims and appeals, including external review procedures. For more information see our SW Benefits Update, “2021 End of Year Plan Sponsor “To Do” List (Part 1) Health and Welfare.”
|
The “outbreak period” ends on the earlier of (1) one year from the date an individual is first eligible for relief, or (2) 60 days after the announced end of the COVID-19 National Emergency. This leads to individual one-year extensions of the deadlines referenced above while the COVID-19 National Emergency is ongoing.
When the COVID-19 National Emergency ends, group health plans may want to consider notifying plan participants about the end of the deadline extensions.
|
Cafeteria Plan Changes: Pursuant to the CAA, IRS Notice 2021-15, and American Rescue Plan Act of 2021 (“ARPA”), employers may make various temporary changes to their cafeteria plans including but not limited to health flexible spending account (“health FSA”) and dependent care assistance plan (“DCAP”) carryover relief and health FSA and DCAP grace period relief. For more information see our SW Benefits Update, “2021 End of Year Plan Sponsor “To Do” List (Part 1) Health and Welfare.”
|
Although most of the temporary changes to cafeteria plans are no longer applicable, group health plans that adopted any of these changes must ensure that they adopt an amendment by the end of the first calendar year beginning after the end of the plan year in which the amendment is effective. For example, an employer with a calendar year plan that permitted participants to carry over unused amounts remaining in their health FSA and/or DCAP from plan year 2021 to plan year 2022, must amend its cafeteria plan to reflect this change by December 31, 2022.
|
Inclusion of COVID-19 Personal Protective Equipment (“PPE”): Pursuant to IRS Announcement 2021-7, Health Savings Accounts (“HSAs”), Archer medical savings accounts, health FSAs, and health reimbursement arrangements (“HRAs”) may reimburse amounts paid for PPE for the primary purpose of preventing the spread of COVID-19 including masks, hand sanitizer, and sanitizing wipes, effective as early as January 1, 2020.
|
These changes appear to be permanent, and therefore employers that want to permit reimbursement for these items should consider amending their plans accordingly.
Pursuant to IRS Announcement 2021-7, an employer may adopt an amendment no later than the last day of the first calendar year beginning after the end of the plan year in which the amendment is effective. However, an amendment with retroactive effect cannot be adopted after December 31, 2022.
|
Long COVID-19 as a Disability: On July 26, 2021, HHS and the Department of Justice issued guidance confirming that “long COVID” is a condition that can qualify as a disability under the Americans with Disabilities Act (“ADA”) and ACA if the condition is a physical or mental impairment that substantially limits one or more major life activities. The guidance notes that long COVID is not always a disability, and employers must assess each individual to determine whether the person’s long COVID condition meets the requirements. This guidance has the potential to provide federal protection to a large group of COVID-19 “long-haulers” against discrimination.
|
These changes appear to be permanent. Employers must be careful that their benefit plans and wellness programs do not discriminate against employees with a COVID-19-related disability
|